CEN is a materials company established in 2013 to revolutionize the application of Mesoporous Silica Nanoparticles (MSNs) and the result of over 20 years of nano materials research on SiO₂ to various industries powering our future industrial revolution, such as advanced medical care, information technology, and auto technology.

Mesoporous Silica is a high-tech material published in more than 12,000 SCI journals worldwide in the past two years alone with applicable technologies in both the medical/biological and advanced innovative industries. In particular, MSNs, which made technological improvements by making Mesoporous Silica into nano sized particles, are seeing an explosive increase in demand as they are used as controlled drug delivery system (DDS) in the medical and bio sectors.

MSNs are materials that can maintain a density in blood that allows them to increase blood circulation time and can provide an optional targeted delivery function that releases drugs only in specific pathological areas.The superior dispersibility of nanoparticles (ranging in the sizes of 20nm to 900nm) in vivo, the low toxicity of the particles, and their affinity to blood which is used as their main method of delivery makes targeted treatment possible with MSNs and can be used as a solution for eliminating potential treatment side effects.

However, due to the lack of eco-friendly mass production methods for producing MSNs, it had been difficult to commercialize them due to toxic waste issues and high production cost until now.

To overcome this problem, CEN presented the first MSN mass-production method in the world in 2019 based on biomineralization and developed a Smart Mesoporous Ball (SMB^TM) technology that can be used as a versatile platform for encapsulating a variety of metal nanoparticles.

Recently, CEN released a product called MesoVita C, which uses SMB^TM technology to continuously nourish the skin with vitamin C and silica underneath the derma for more than 24 hours and to help with comprehensive skin care.

Also, SMB^TM products that encapsulate nanoparticles such as Au, Pt, Ag, etc. - without the toxicity of nanoparticles - are considered the must-have products for this generation that is combating coronavirus as they are novel nanomaterials with high anti-bacterial and anti-virus properties that do not show cytotoxicity, and they also have photoplasmonic effects, photothermal effects, and superoxides.

Lastly, as a result of plasmonic research technology using the encapsulation of silver (Ag) nanoparticles inside SMB^TM (in cooperation with KIMS), a technology research paper covering the 36% increase of DSSC fiber generation efficiency was published as the cover paper of "Nano Research" on January 2. 2021.